NCT04790617Completed
ENCOMPASS: Expansion Study B, RCT
Enhancing Community Health Through Patient Navigation, Advocacy and Social Support (ENCOMPASS): Expansion Study B, A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 23 May 2024
Brief summary (registry, in English)
Some patients living with multiple long-term health conditions have difficulty accessing the services they need, despite available primary care and community resources. Patient navigation programs may help those with complex health conditions to improve their care and outcomes. Community health navigators (CHNs) are community members who help guide patients through the health care system. CHNs are not health professionals like a doctor or nurse, but they are specially trained to help patients get the most out of their health care and connect them to resources. The ENCOMPASS program of research evaluates a patient navigation program that connects patients living with long-term health conditions to CHNs. To understand if the CHN program can be scaled to a provincial level, the ENCOMPASS program of research is expanding to select primary care settings across Alberta. This study implements and evaluates the CHN program at Calgary West Central Primary Care Network in Calgary, Alberta, Canada.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 183 (actual)
- First submitted
- 13 Jan 2021
- Start date
- 1 Mar 2021
- Primary completion date
- 10 Nov 2022
- Lead sponsor
- University of Calgary
- Diseases
- Chronic kidney disease, Heart failure, Coronary artery disease, Asthma, COPD, High blood pressure, Type 2 diabetes
- NCT number
- NCT04790617
What you commit to
- Study type: Interventional
- Participants enrolled: 183
- From 1 Mar 2021 to the primary completion date, 10 Nov 2022
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patient unable to provide informed consent;
- Patient residing in long-term care facility;
- Health care provider discretion.
Who the study is looking for
- Poorly controlled hypertension (most recent systolic blood pressure \> 160 mmHg or labile);
- Poorly controlled diabetes (A1C \> 9% on at least one occasion within the past year or labile);
- Stage 3b or greater chronic kidney disease (estimated glomerular filtration rate \< 45 mL/min/1.73m2 in past year);
- Established ischemic heart disease (at least one instance of a physician billing diagnosis with a relevant International Classification of Diseases, 9th Edition \[ICD-9\] code recorded in electronic medical record (EMR), or known to health care team);
- Congestive heart failure (at least one instance of a physician billing diagnosis with a relevant ICD-9 code recorded in EMR, or known to health care team);
- Chronic obstructive pulmonary disease OR Asthma with at least two visits in the past year (at least 2 instances of a physician billing diagnosis with a relevant ICD-9 code, or known to health care team).
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Calgary West Central Primary Care Network Coordinator of this site? Confirm its status | Calgary | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.